The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 25, 2025

Filed:

Aug. 02, 2021
Applicant:

Taro Pharmaceutical Industries Ltd., Haifa Bay, IL;

Inventors:

Vered Rosenberger, Givatayim, IL;

Helena Shifrin, Rehovot, IL;

Irena Oleinik, Karmiel, IL;

Tzviel Sheskin, Haifa, IL;

Ron Schlinger, Tel Aviv, IL;

Avi Avramoff, Haifa, IL;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/47 (2006.01); A61K 9/00 (2006.01); A61K 9/107 (2006.01); A61K 47/10 (2017.01); A61P 17/04 (2006.01);
U.S. Cl.
CPC ...
A61K 31/47 (2013.01); A61K 9/0014 (2013.01); A61K 9/1075 (2013.01); A61K 47/10 (2013.01); A61P 17/04 (2018.01);
Abstract

The present disclosure provides for topical emulsion comprising about 0.5% to about 10% Montelukast or pharmaceutically acceptable salt thereof; and about 0.4% to about 4% carbomer; wherein particles comprising the Montelukast in the emulsion have D90 of less than about 50 μm, wherein the Montelukast or pharmaceutically acceptable salt thereof is homogeneously dispersed in the emulsion, and wherein the emulsion has a pH of about 3.0 to about 6.5. The present disclosure also provides a topical gel comprising (a) about 0.5% to about 10% Montelukast or pharmaceutically acceptable salt thereof; (b) about 0.2% to about 8% cellulose polymer; and (c) about 80% to about 95% amphiphilic compound; wherein the gel comprises less than 4% water.


Find Patent Forward Citations

Loading…